SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,570 | -57.4% | 10,954 | -7.7% | 0.00% | – |
Q2 2023 | $15,432 | -72.3% | 11,871 | -62.5% | 0.00% | – |
Q1 2023 | $55,739 | -43.9% | 31,670 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $99,444 | -21.1% | 31,670 | +23.5% | 0.00% | 0.0% |
Q3 2022 | $126,000 | +17.8% | 25,641 | -0.9% | 0.00% | 0.0% |
Q2 2022 | $107,000 | -32.3% | 25,874 | -5.0% | 0.00% | 0.0% |
Q1 2022 | $158,000 | -31.6% | 27,241 | -11.6% | 0.00% | 0.0% |
Q4 2021 | $231,000 | -18.4% | 30,809 | -1.9% | 0.00% | -50.0% |
Q3 2021 | $283,000 | -24.7% | 31,405 | +0.1% | 0.00% | 0.0% |
Q2 2021 | $376,000 | -1.6% | 31,385 | +2.9% | 0.00% | 0.0% |
Q1 2021 | $382,000 | +49.2% | 30,486 | +85.8% | 0.00% | 0.0% |
Q4 2020 | $256,000 | +65.2% | 16,411 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $155,000 | +5.4% | 16,411 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $147,000 | +70.9% | 16,411 | +21.8% | 0.00% | 0.0% |
Q1 2020 | $86,000 | +48.3% | 13,477 | +95.7% | 0.00% | – |
Q4 2019 | $58,000 | -6.5% | 6,887 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $62,000 | -16.2% | 6,887 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $74,000 | +17.5% | 6,887 | +4.1% | 0.00% | 0.0% |
Q1 2019 | $63,000 | -19.2% | 6,618 | -2.5% | 0.00% | 0.0% |
Q4 2018 | $78,000 | -12.4% | 6,787 | +29.6% | 0.00% | 0.0% |
Q3 2018 | $89,000 | +32.8% | 5,235 | +11.1% | 0.00% | 0.0% |
Q2 2018 | $67,000 | -25.6% | 4,711 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $90,000 | +16.9% | 4,711 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $77,000 | +120.0% | 4,711 | +100.7% | 0.00% | – |
Q3 2017 | $35,000 | +66.7% | 2,347 | 0.0% | 0.00% | – |
Q2 2017 | $21,000 | +75.0% | 2,347 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | +71.4% | 2,347 | 0.0% | 0.00% | – |
Q4 2016 | $7,000 | -36.4% | 2,347 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | -21.4% | 2,347 | 0.0% | 0.00% | – |
Q2 2016 | $14,000 | 0.0% | 2,347 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -33.3% | 2,347 | 0.0% | 0.00% | – |
Q4 2015 | $21,000 | +320.0% | 2,347 | +164.3% | 0.00% | – |
Q3 2015 | $5,000 | +25.0% | 888 | +176.6% | 0.00% | – |
Q2 2015 | $4,000 | -20.0% | 321 | 0.0% | 0.00% | – |
Q1 2015 | $5,000 | – | 321 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |